These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2005-001360-31||A multicenter, randomised, double- blind, between-patient, dose finding study to assess the safety, tolerability and efficacy of three different dosages (500, 1000 and 2000 mcg/g) of ABIO 12/01 gel, i...||bad-data|
|Completed, but no date||2006-003643-23||Efficacy and tolerability study of a novel CNS drug ABIO 08/01 administered for 8 weeks to patients with generalised anxiety disorders||bad-data|
|Completed, but no date||2007-001060-80||A multicenter, parallel-group, double-blind, randomized, placebo-controlled, increasing-dose study, to evaluate preliminarily the clinical effects, the safety and tolerability of ABIO 08/01, in patien...||bad-data|
|Completed, but no date||2007-003372-18||A randomised, double-blind, placebo controlled study to assess the safety and the efficacy of neridronate 100 mg - 4 i.v. infusions in a course of 10 days treatment - in patients with algodystrophic s...||bad-data|
|Completed, but no date Terminated||2007-005195-14||A monocentre, randomised, double-blind, between-patient study to compare the effect of Vitamin D 300.000 IU orally vs placebo on bone metabolism, muscolar function, vascular system and infection in pa...||bad-data|
|Ongoing||2014-001156-28||A randomized, double-blind, placebo controlled study to assess the safety and the efficacy of Neridronate ampoules 25 mg, after repeated intramuscular administrations, in patients with Complex Regiona...||not-yet-due|
|Ongoing||2018-002081-39||A randomised, double-blind, parallel-group, multicenter, placebo-controlled, dose-ranging study, to evaluate the efficacy and safety of clodronate ampoules at different dosages, after intra-articular ...||not-yet-due|